Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Tekmira Pharmaceuticals Corp (NASDAQ:TKMR)

10.89
BATS BZX Real-Time Price
As of 2:17pm ET
 +0.64 / +6.24%
Today’s Change
10.02
Today|||52-Week Range
29.93
-28.12%
Year-to-Date
No recent news for Tekmira Pharmaceuticals Corp.

Today’s Trading

Previous close10.25
Today’s open10.25
Day’s range10.07 - 11.03
Volume453,610
Average volume (3 months)681,712
Market cap$555.6M
Dividend yield--
Data as of 2:03pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-95.65%
Earnings growth (this year)--
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-3.31%
P/E ratio--
Price/Sales22.17
Price/Book2.61

Competitors

 Today’s
change
Today’s
% change
DERMDermira Inc-0.10-0.44%
CHMAChiasma Inc+0.47+2.03%
CORTCorcept Therapeutics...+0.05+1.00%
VSARVersartis Inc+0.20+1.12%
Data as of 2:03pm ET, 07/31/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$15.0M
Annual profit (last year)-$38.8M
Net profit margin-259.73%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Murray
Chief Operating Officer
Patrick T. Higgins
Corporate headquarters
Burnaby, British Columbia

Forecasts